Allscripts announces second quarter 2016 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Allscripts (MDRX) PT Raised to $15 at Piper Jaffray
August 5, 2016 8:10 AM EDTPiper Jaffray analyst Sean Wieland reiterated a Neutral rating but bumped his price target on Allscripts (NASDAQ: MDRX) to $15.00 (from $12.00) following record bookings driven by OptumCare win.
Wieland commented, "Allscripts beat bookings with the announcement of a win at OptumCare, a division of... More
Allscripts (MDRX) Reports In-Line Q2 EPS
August 4, 2016 4:04 PM EDTAllscripts (NASDAQ: MDRX) reported Q2 EPS of $0.14, in-line with the analyst estimate of $0.14. Revenue for the quarter came in at $386.5 million versus the consensus estimate of $403.13 million.
For earnings history and earnings-related data on Allscripts (MDRX) click here.
... More